Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates

Non-small-cell lung cancer (NSCLC) is a major health burden, and novel therapeutic options are needed to help solve this problem. One such option is immunotherapy, which targets immune checkpoint molecules that inhibit cancer cells, decreasing immune system activation, for example, immunotherapies t...

Descripción completa

Detalles Bibliográficos
Autores principales: Suraya, Ratoe, Tachihara, Motoko, Nagano, Tatsuya, Nishimura, Yoshihiro, Kobayashi, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234310/
https://www.ncbi.nlm.nih.gov/pubmed/35769229
http://dx.doi.org/10.2147/CMAR.S366738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234310/
https://www.ncbi.nlm.nih.gov/pubmed/35769229
http://dx.doi.org/10.2147/CMAR.S366738

Ejemplares similares